Pulished Date October, 2018
ID: 852
Share on
Share on

Middle-East And Africa Bovine Respiratory Disease Treatment Market By Type Of Treatment (Anti-Infectious Agents (antibiotics And Sulfas), Anti-Parasiticides, Bronchodilators, Oral Rehydration Fluids, Non-Steroidal Anti-Inflammatories, And Mucolytic), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: October, 2018
ID: 852
Pages: 137

The Middle-East and Africa Bovine Respiratory Disease Treatment Market has been estimated at USD 3.28 million in 2018 and is projected to reach USD 8.9 million by 2023, at a CAGR of 22.1% during the forecast period from 2018 to 2023.

Bovine respiratory disease (BRD) has a multifactorial, polymicrobial etiology. Organisms known to be related with BRD include bacteria and viruses. BRD is a shared health problem for both dairy and beef cattle, ensuing in economic loses. There are many factors that combine to cause disease. No two scenarios are precisely same but they often culminate in severe and fatal bacterial pneumonia.

Bovine respiratory disease complex (BRDC) is a substantial reason of mortality and morbidity in cattle; resulting into loss of million dollars annually for the dairy and beef industries, even with the use of vaccines and antibiotics. 

The Middle-East and Africa bovine respiratory disease treatment market has been segmented on the basis of type of treatment into anti-infectious agents, anti-parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment. Middle-East and Africa market is geographically segmented into Middle-East and Africa.

The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Infectious Agents                       



                                5.1.2 Anti-Parasiticides                 

                                5.1.3 Bronchodilators                    

                                5.1.4 Oral Rehydration Fluids                     

                                5.1.5 Non-Steroidal Anti-Inflammatories               

                                5.1.6 Mucolytics                              

6. Geographical Analysis                                                              

                6.1 Introduction                                              

                6.2 Middle-East                                                

                6.3 Africa                                            

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Zoetis Inc.                                   

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Merck & Co. Inc.                                       

                8.3 Bayer Corporation                                   

                8.4 Eli Lilly & Co.                                              

                8.5 Merial S.A.S                               

                8.6 Boehringer Ingelheim Vetmedica                                     

                8.7 Novartis Animal Health                                          

                8.8 Vibrac S.A                                   

                8.9 Ceva Sante Animale                                

                8.10 Vétoquinol S.A.                                      

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 


                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Bovine Respiratory Disease Treatment Market By Region, From 2018–2023 (USD Million)
  2. Middle East & Africa Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  3. Middle East & Africa Anti-Infectious Agents Market By Region, From 2018–2023 (USD Million)
  4. Middle East & Africa Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  5. Middle East & Africa Antibiotics Market By Region, From 2018–2023 (USD Million)
  6. Middle East & Africa Sulfas Market By Region, From 2018–2023 (USD Million)
  7. Middle East & Africa Anti-Parasiticides Market By Region, From 2018–2023 (USD Million)
  8. Middle East & Africa Bronchodilators Market By Region, From 2018–2023 (USD Million)
  9. Middle East & Africa Oral Rehydration Fluids Market By Region, From 2018–2023 (USD Million)
  10. Middle East & Africa Non-Steroidal Anti-Inflammatories Market By Region, From 2018–2023 (USD Million)
  11. Middle East & Africa Mucolytic Market By Region, From 2018–2023 (USD Million)
  12. Middle East Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  13. Middle East Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)
  14. Africa Bovine Respiratory Disease Treatment Market By Type of Treatment, From 2018–2023 (USD Million)
  15. Africa Bovine Respiratory Disease Treatment Market By Anti-Infectious Agents, From 2018–2023 (USD Million)


$ 1234 2875